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Changes in Antimicrobial Resistance in
Salmonella enterica Serovar Typhimurium
To the Editor: The conclusion by Davis and
colleagues (1) that use of antimicrobial agents
in agriculture is unlikely to have contributed to
the emergence of multidrug-resistant
Salmonella serotype Typhimurium DT104 (MR-
DT104) is contrary to available evidence. Use of
antimicrobial agents in aquaculture in Asia
may have contributed to the emergence of
DT104. The resistant determinants of MR-
DT104 reside on the chromosome, apparently
within a transferrable element (2-4).
Chloramphenicol resistance in MR-DT104 is
due to floR, a florfenicol resistance gene (5);
florfenicol is a veterinary antimicrobial agent
that, although not approved in the United
States until 1996, has been used in aquaculture
in Asia since the early 1980s. FloR was first
identified in Photobacterium damsela, a
bacterium found in fish (5). Furthermore,
tetracycline resistance in MR-DT104 is due to a
class G resistance gene first identified in Vibrio
anguillarum, a pathogen of fish (4,6). The
molecular sequence where the class G and floR
determinants reside on the DT104 chromosome
is closely related (94% identity) to a plasmid in
Pasteurella piscicida, another pathogen of fish
(7). These data suggest that the resistance
determinants of MR-DT104 may have emerged
among bacteria in aquaculture and been
horizontally transferred to
S. Typhimurium DT104.
Spread of MR-DT104 between regions
during international travel, as Davis and
colleagues suggest, is unlikely because in
industrialized countries Salmonella is seldom
transmitted from person to person (8). Once
MR-DT104 emerged, it spread rapidly to many
regions through unknown means. The rapid
emergence of MR-DT104 suggests a means of
spread more efficient than person-to-person
transmission. Possibilities include movement of
infected breeding or “multiplier” stock or
shipment of contaminated feed ingredients;
such movements may not be as limited as Davis
et al. suggest. For example, the international
spread of Salmonella serotype Agona was
traced to the global distribution of contami-
nated fish meal from Peru (9).
Once MR-DT104 is introduced into food
animals in a region, use of antimicrobial agents
in animals would contribute to further dissemi-
nation of MR-DT104 (8). If MR-DT104 is
present on a farm, the use on the farm of any
antimicrobial agent to which MR-DT104 is
resistant would contribute to its persistence. An
example of such use in cattle in the United
States is the tetracycline-containing milk
“replacement” commonly fed to dairy calves.
This product could kill susceptible gastrointes-
tinal flora while allowing tetracycline-resistant
flora such as MR-DT104 to survive and prolifer-
ate. Once MR-DT104 proliferates on a farm,
dissemination to other farms in the region is
facilitated, particularly if the other farms are
using an antimicrobial agent to which MR-
DT104 is resistant.
Increasing antimicrobial resistance in
Salmonella contributes to its spread and
threatens the use of clinically important antimi-
crobial agents. To slow the emergence and
dissemination of resistant Salmonella, mea-
sures should be implemented to ensure that
antimicrobial agents are used prudently in
food-producing animals (10).Letters
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Reply to Drs. Angulo and Collignon
To the Editor: Drs. Angulo and Collignon point
out that exposure to one antimicrobial drug
(e.g., tetracycline) can confer a selective
advantage to a multiresistant organism (e.g., R-
type ACSSuT) over nonresistant organisms.
However, tetracycline use would not be
expected to favor one tetracycline-resistant
organism (MR-DT104) over other tetracycline-
resistant organisms, and most bovine
Typhimuriums before the MR-DT104 epidemic
were tetracycline-resistant R-type ASSuT.
Since neither florfenicol nor chloramphenicol
was then available for use in livestock in the
United States, the evidence suggests that the
emergence of MR-DT104 in cattle populations
was not driven by antibiotic selection pressure.
The references Drs. Angulo and Collignon cited
to establish the importance of antimicrobial use
in livestock for the dissemination of
multiresistant clones either do not address the
issue of dissemination (1-2) or present evidence
to the contrary: the dissemination of
fluoroquinolone-resistant MR-DT104 despite
the lack of fluoroquinolone use in the herds in
question (3).
Available data support Dr. Collignon’s
example of Campylobacter as an agent for
which fluoroquinolone use in livestock resulted
in increasing prevalence of fluoroquinolone
resistance (4). However, the epidemiology of
resistance in polyclonal commensals such as
Campylobacter is very unlike that of epidemic,
clonal S. Typhimuriums. The epidemic, clonal
dissemination of S. Typhimurium more closely
resembles that of methicillin-resistant Staphy-
lococcus aureus (MRSA). Epidemic MRSA
clones differ genetically from nonepidemic ones,
and dissemination of epidemic clones does not
necessarily require antimicrobial selection
pressure (5). Because antimicrobial usage
practices that contribute to the control of MRSA
have not been scientifically defined, infection
control practices must play the central role in
successful MRSA control programs (6-8).
Dr. Angulo’s hypothesis that MR-DT104
emerged genetically in Asian fish is plausible,
but other credible hypotheses exist. tet(G), first
described in Vibrio angullarium, also occurs in
Pseudomonas aeruginosa (9). Similarly, floR is
closely related to the P. aeruginosa
chloramphenicol-resistance gene cmlA (10), and
pse-1 encoded beta-lactamase is a common
feature of hospital P. aeruginosa isolates (11).
Thus, the hypothesis that MR-DT104 acquired
resistance genes horizontally from nosocomial
pseudomonads might also be worthy of
consideration.